CG
AVNS icon

Caprock Group’s Avanos Medical AVNS Stock Holding History

Caprock Group’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,307
Closed -$227K – 364
2018
Q3 		$227K Buy
+3,307
New +$213K 0.05% 332
2018
Q1 		– Sell
-11,062
Closed -$546K – 451
2017
Q4 		$546K Hold
11,062
– – 0.11% 190
2017
Q3 		$498K Hold
11,062
– – 0.1% 188
2017
Q2 		$435K Buy
11,062
+3
+0% +$113 0.1% 199
2017
Q1 		$421K Sell
11,059
-1,047
-9% -$40.8K 0.1% 182
2016
Q4 		$448K Hold
12,106
– – 0.11% 166
2016
Q3 		$420K Buy
+12,106
New +$424K 0.1% 200

Other funds holding AVNS

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return